- Home
- WOLF vs GNFT Comparison
WOLF vs GNFT Comparison
Compare WOLF & GNFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOLF
- GNFT
- Stock Information
- Founded
- WOLF 1987
- GNFT 1999
- Country
- WOLF United States
- GNFT France
- Employees
- WOLF N/A
- GNFT N/A
- Industry
- WOLF Semiconductors
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WOLF Technology
- GNFT Health Care
- Exchange
- WOLF Nasdaq
- GNFT Nasdaq
- Market Cap
- WOLF 200.8M
- GNFT 186.3M
- IPO Year
- WOLF 1993
- GNFT 2019
- Fundamental
- Price
- WOLF $1.46
- GNFT $3.75
- Analyst Decision
- WOLF Hold
- GNFT Strong Buy
- Analyst Count
- WOLF 14
- GNFT 1
- Target Price
- WOLF $10.67
- GNFT $13.00
- AVG Volume (30 Days)
- WOLF 216.3M
- GNFT 4.0K
- Earning Date
- WOLF 08-20-2025
- GNFT 04-24-2025
- Dividend Yield
- WOLF N/A
- GNFT N/A
- EPS Growth
- WOLF N/A
- GNFT N/A
- EPS
- WOLF N/A
- GNFT 0.03
- Revenue
- WOLF $761,300,000.00
- GNFT $73,187,701.00
- Revenue This Year
- WOLF N/A
- GNFT $15.98
- Revenue Next Year
- WOLF $11.97
- GNFT N/A
- P/E Ratio
- WOLF N/A
- GNFT $120.71
- Revenue Growth
- WOLF N/A
- GNFT 105.01
- 52 Week Low
- WOLF $0.39
- GNFT $2.55
- 52 Week High
- WOLF $3.33
- GNFT $6.42
- Technical
- Relative Strength Index (RSI)
- WOLF 52.05
- GNFT 44.52
- Support Level
- WOLF $0.55
- GNFT $3.44
- Resistance Level
- WOLF $3.33
- GNFT $3.81
- Average True Range (ATR)
- WOLF 0.39
- GNFT 0.17
- MACD
- WOLF 0.22
- GNFT -0.00
- Stochastic Oscillator
- WOLF 41.33
- GNFT 56.65
About WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.